A novel neuroprotectant granulocyte-colony stimulating factor
- PMID: 16514095
- DOI: 10.1161/01.STR.0000208205.26253.96
A novel neuroprotectant granulocyte-colony stimulating factor
Abstract
Background and purpose: Granulocyte-colony stimulating factor (G-CSF) is a growth factor that orchestrates the proliferation, differentiation, and survival of hematopoietic progenitor cells. It has been used for many years in clinical practice to accelerate the recovery of patients from neutropenia after cytotoxic therapy. However, there is a growing body of evidence from experimental studies suggesting that G-CSF also has important nonhematopoietic functions in the central nervous system.
Summary of review: The presence of the G-CSF/G-CSF-receptor system in the brain and its role in neuroprotection and neural tissue repair has been investigated in many recent studies. The neuroprotective actions of G-CSF have mainly been attributed to its anti-inflammatory and antiapoptotic effects. Furthermore, it induces neurogenesis and angiogenesis and improves functional recovery. In this review, we summarize the role of G-CSF and the corresponding signal transduction pathways regulated by G-CSF in neuroprotection.
Conclusions: Much additional work is needed to better understand the precise mechanisms of G-CSF-induced neuroprotection. However, there is emerging data suggesting that G-CSF is a potential new agent for neuroprotection.
Comment in
-
Developing granulocyte-colony stimulating factor for the treatment of stroke: current status of clinical trials.Stroke. 2006 Jul;37(7):1654; author reply 1655. doi: 10.1161/01.STR.0000227299.62106.0e. Epub 2006 May 25. Stroke. 2006. PMID: 16728676 No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
